Chemical Compound Review:
CHEMBL281812 5-[bis(2-chloroethyl)amino]- 2,4-dinitro...
Synonyms:
ACMC-1C65P, AG-D-84048, CHEBI:126457, NSC-646392, SN-23862, ...
- Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase. Anlezark, G.M., Melton, R.G., Sherwood, R.F., Wilson, W.R., Denny, W.A., Palmer, B.D., Knox, R.J., Friedlos, F., Williams, A. Biochem. Pharmacol. (1995)
- Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form. Johansson, E., Parkinson, G.N., Denny, W.A., Neidle, S. J. Med. Chem. (2003)
- Nitroreductase-based GDEPT. Denny, W.A. Curr. Pharm. Des. (2002)
- Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5. Kestell, P., Pruijn, F.B., Siim, B.G., Palmer, B.D., Wilson, W.R. Cancer Chemother. Pharmacol. (2000)
- Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase. Atwell, G.J., Boyd, M., Palmer, B.D., Anderson, R.F., Pullen, S.M., Wilson, W.R., Denny, W.A. Anticancer Drug Des. (1996)
- 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. Helsby, N.A., Ferry, D.M., Patterson, A.V., Pullen, S.M., Wilson, W.R. Br. J. Cancer (2004)